Search

everythinglearnresearchcommunity

for

Search:↓

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Active treatment can help prevent scarring hair loss in SLE patients.

Eclipta alba extract reduces ulcers and protects the stomach in rats.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

LC-OCT can help identify lupus-related scarring hair loss by spotting unique features.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

The document's conclusion cannot be determined from the provided text.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Blood and urine markers are important for diagnosing lupus in children.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

People with Epidermolysis bullosa have many health problems including poor oral health, which is often neglected due to other medical issues.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Erythema multiforme-like lesions can occur in lupus without drug use or herpes infection.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Upadacitinib improved multiple immune-related conditions in one patient.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The document's conclusion cannot be provided because the content is not accessible.

Zinc treatment improved skin and hair issues in a boy with a zinc-related condition.